Bart Staels (Lille, FRA)

Bart Staels (Lille, FRA)

(Speaker)
Bart Staels, PhD., is director of the Inserm Unit UMR1011 with laboratories at the Lille Pasteur Institute and Medical Faculty campus. After his doctorate at the Univ.Leuven, Belgium, he completed his training at the UCSF, San Francisco and RPR, Paris. He is Senior Member of the Institut Universitaire de France (2011-16), co-founder and board member of the European Genomic Institute for Diabetes (EGID, Lille), member of the French National Academy of Pharmacy (2011-) and the Belgian Royal Academy of Medicine (2022-). Past-president of the French Atherosclerosis Society (NSFA; 2009-2011). Awards: the EAS Young Investigator Award, the CNRS Bronze Medal, the Lifetime Achievement Award of the British Atherosclerosis Society, the “Barré” prize from the Faculté de Pharmacie of Montreal (2007), the “JP Binet” prize from the Fondation pour la Recherche Médicale (2011), the “Distinguished Leader in Insulin Resistance” award (ICIR; 2012) and the ICBL Laurens van Deenen award (2017). B.Staels’ research covers the fields of obesity, diabetes, hepatic and cardiovascular diseases focussing on molecular pharmacology of these cardio-metabolic diseases. He particularly studies the role of nuclear receptors in the control of inflammation and lipid and glucose homeostasis as well as the transcriptional mechanisms involved. B.Staels has published >900 articles, abstracts and book chapters. He received the ISI citations award, ranked in the 2018 and 2022 Highly Cited Researchers list of Clarivate Analytics; and the Google Scholar h-index 2019 list. In 2022, he was ranked #1 in France in the Top 1000 Scientists in the field of Medicine by Research.com